Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (23 ops.)
Latest filing published 03 Aug 2026 for Globe Life INC., €64k.
Filing timeline
BuySaleJames Matthew Darden
Insider track record
Disclosed buys
2
Disclosed sells
23
Signal history
Closed purchases
Market purchases
2
Positive at T+90
100%
Median T+90
+19.4%
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +48.2%Entry US$80.55 · Close at T+365 US$119.41
- +44.2%Entry US$83.33 · Close at T+365 US$120.20
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
James Matthew Darden: trading record in brief
James Matthew Darden is Co-Chairman & CEO of Globe Life Inc., the only company in a record of 60 filings published from January 5, 2018 to August 3, 2026. Volume is accelerating: 2 filings in 2020 and 2022, 12 in 2025 and 16 in 2026.
The 21 open-market sales total EUR 27,753,532, with a median of EUR 959,327. The three largest are EUR 7,855,729 on July 31, 2026, then EUR 2,288,959 and EUR 2,288,913, both on March 4, 2026. The 2 purchases, from May 16, 2024 (EUR 156,100) and May 21, 2024 (EUR 76,254), weigh EUR 232,354 and make up 9% of market trades. The rest: 23 share grants, 10 option exercises and 4 filings of another kind.
Over the last twelve months, 16 filings are recorded, 7 of them sales. They are published a median of 2 days after the trade.
At Globe Life, Frank M. Svoboda has 19 trades within 30 days of Darden's, Michael Clay Majors 14, Michael Shane Henrie 13, Thomas Peter Kalmbach 10 and Rebecca E. Zorn 11, 9 of them in the same direction.
Companies and markets linked to James Matthew Darden
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations60 total
400 shares@ US$183.35750.0006% mcap0.3% of flowCommon StockSEC:0000320335-26-000214:2
50,000 shares@ US$98.320.037% mcap20.0% of flowCommon StockSEC:0000320335-26-000214:0
49,600 shares@ US$182.42530.069% mcap36.8% of flowCommon StockSEC:0000320335-26-000214:1
4,663 shares@ US$100.740.0033% mcap1.9% of flowCommon StockSEC:0000320335-26-000151:0
4,663 shares@ US$153.87730.0050% mcap2.9% of flowCommon StockSEC:0000320335-26-000151:1
18,318 shares@ US$145.102910.7% of flowCommon StockSEC:0000320335-26-000149:1
7,358 shares0Common StockSEC:0000320335-26-000128:1
18,318 shares@ US$100.743.3% of flowCommon StockSEC:0000320335-26-000128:2
18,318 shares@ US$145.104.8% of flowCommon StockSEC:0000320335-26-000128:3
7,358 shares0Common StockSEC:0000320335-26-000128:0
4,591 shares0Common StockSEC:0000320335-26-000110:4
9,641 shares@ US$144.152.5% of flowCommon StockSEC:0000320335-26-000110:1
6,471 shares@ US$144.141.7% of flowCommon StockSEC:0000320335-26-000110:2
3,056 shares@ US$144.760.8% of flowCommon StockSEC:0000320335-26-000110:3
24,499 shares0Common StockSEC:0000320335-26-000110:0
1,343 shares@ US$144.390.8% of flowCommon StockSEC:0000320335-26-000064:0
33,270 shares@ US$82.564.9% of flowCommon StockSEC:0001062993-25-013184:1
17,237 shares@ US$134.564.2% of flowCommon StockSEC:0001062993-25-013184:2
1,556 shares@ US$135.650.4% of flowCommon StockSEC:0001062993-25-013184:3
9,753 shares@ US$136.522.4% of flowCommon StockSEC:0001062993-25-013184:4
4,724 shares@ US$137.411.2% of flowCommon StockSEC:0001062993-25-013184:5
0.467 shares@ US$137.5150.0% of flowCommon StockSEC:0001062993-25-013184:0
3,686 shares0Common StockSEC:0001062993-25-003993:2
4,662 shares@ US$121.931.1% of flowCommon StockSEC:0001062993-25-003993:1
11,845 shares0Common StockSEC:0001062993-25-003993:0
25 of 60 declarations
